Advertisement

Topics

Syneron Medical Company Profile

22:36 EDT 22nd June 2018 | BioPortfolio

Syneron manufactures and sells non-ablative medical aesthetic devices that use the patented elos technology, the only combined energy system with applications for wrinkle treatment, skin treatment, cellulite reduction, acne treatment, Rosacea treatment, hair removal, leg vein and spider vein treatment, and more. elos technology, which combines Radio Frequency and Light energies is sold to dermatologists, plastic surgeons, physicians, estheticians and medical spa professionals.

Location

111 Granton Drive, Unit 110
Richmond Hill
Ontario
L4B 1L5
Canada

Contact

Phone: 905-886-9235
Fax: 905-886-7046
Email: info@syneron.com


News Articles [177 Associated News Articles listed on BioPortfolio]

TruDerm Dermatology to Offer Unique Profound Treatment for Wrinkles, Jawline and Submental Areas

TruDerm Dermatology, located in Watters Creek, is pleased to announce the addition of Profound, by Syneron-Candela to its platform of laser technology for the treatment of medical and cosmetic procedu...

Syneron Medical Ltd Medical Equipment Deals and Alliances Profile [Report Updated: 13022018] Prices from USD $250

SummarySyneron Medical Ltd Syneron is an aesthetic medical device company. It designs, develops and markets aesthetic medical products. The company products target a range of noninvasive aesthetic med...

Global and Europe Medical Laser Systems Market Status and Future Forecast 20132023 [Report Updated: 10012018] Prices from USD $3500

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPar...

Medical Imaging Equipment Market to Gain From Extensive R&D Activities in Order to ...

The process of medical imaging is normally of two types entailing classical medical imaging and contemporary medical imaging. The most common medical imaging is X-Rays Read more...

20152023 World Varicose Vein Treatment Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 08012018] Prices from USD $2800

SummaryThere are several treatment options for Varicose Veins, wearing support stockings, Varicose Vein Treatment Devices; endogenous laser treatment, radiofrequency occlusion, surgery, and lasers and...

Confluent Medical Technologies acquires Corpus Medical

Confluent Medical Technologies, a provider of medical device contract manufacturing services, has completed the acquisition of Corpus Medical.

Global and Regional Varicose Vein Treatment Market Research Report 2017 [Report Updated: 08122017] Prices from USD $3500

SummaryThere are several treatment options for Varicose Veins, wearing support stockings, Varicose Vein Treatment Devices; endogenous laser treatment, radiofrequency occlusion, surgery, and lasers and...

How health IT enables safer medical travel and tourism

IT innovation, global medicine and frustrated medical patients drive the demand for medical travel. But telemedicine also improves patient care and the customer experience of medical travelers. Once a...

Drugs and Medications [0 Results]

None

PubMed Articles [1786 Associated PubMed Articles listed on BioPortfolio]

Medical Marijuana Users are More Likely to Use Prescription Drugs Medically and Nonmedically.

Previous studies have found a negative population-level correlation between medical marijuana availability in US states, and trends in medical and nonmedical prescription drug use. These studies have ...

Medical specialty preferences in early medical school training in Canada.

To understand what medical students consider when choosing their specialty, prior to significant clinical exposure to develop strategies to provide adequate career counseling.

Strategies for enhancing medical student resilience: student and faculty member perspectives.

To improve programs aimed to enhance medical student resiliency, we examined both medical student and faculty advisor perspectives on resiliency-building in an Asian medical school.

Improving medical students' confidence with supplemental training programs: a medical student's view.

The Suffering Medical Students Attribute to Their Undergraduate Medical Education.

The purpose of this study was to explore medical student perceptions of their medical school teaching and learning about human suffering and their recommendations for teaching about suffering. During ...

Clinical Trials [1599 Associated Clinical Trials listed on BioPortfolio]

Performance of Profound System

Prospective clinical study to evaluate the Profound efficiency Up to 60 healthy adult volunteers, male or females, 18 to 70 years old. All subjects in this study will receive a single trea...

EVALUATION OF THE EFFECT OF THE PERFECTA V-BEAM LASER ON ROSACEA

The purpose of this study is to further quantify the safety and effectiveness of the Syneron-Candela long pulse-duration, extended sub-pulse, larger spot-size prototype Perfecta V-Beam, 59...

Interventional Study to Evaluate the Appearance of Surgical Scars After Laser Therapy

This study evaluates the effect of a fractionated carbon dioxide laser on surgical scars of the face and neck over 12 months. Anyone with a surgical scar on the face and neck who has not h...

Doctor-Parent Interactions With Medical Scribes

The purpose of the study is to collect outcomes related to a quality improvement project assessing the feasibility and effectiveness of a medical scribe program in which medical scribes ac...

Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation

PCI (optimal catheter-based coronary revascularization) + intensive medical therapy is superior to intensive medical therapy alone using the combined endpoint of all-cause mortality or non...

Companies [1182 Associated Companies listed on BioPortfolio]

Candela Corporation

Candela is a wholly-owned subsidiary of Syneron Medical Ltd. (NASDAQ: ELOS), the global leader of aesthetic devices offering the industry's most comprehensive product portfolio and worldwide distribut...

Syneron Medical

Syneron manufactures and sells non-ablative medical aesthetic devices that use the patented elos technology, the only combined energy system with applications for wrinkle treatment, skin treatment, ce...

Syneron Medical Ltd.

Syneron Candela is a leading global non-surgical aesthetic device company with a comprehensive product portfolio and a global distribution footprint. The Company's technology enab...

Chemence Medical, Inc.

Chemence Medical, Inc., headquartered in metropolitan Atlanta, GA, has redefined the medical adhesives industry, and has become a world leader in the medical device arena since it...

Allegro Medical

Allegro Medical, member of the Scrip Companies family, is the country’s leading online medical supply store for durable medical equipment and medical supplies. Allegro...

More Information about "Syneron Medical" on BioPortfolio

We have published hundreds of Syneron Medical news stories on BioPortfolio along with dozens of Syneron Medical Clinical Trials and PubMed Articles about Syneron Medical for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Syneron Medical Companies in our database. You can also find out about relevant Syneron Medical Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Dermatology
Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...

Acne
Acne is a common skin condition that causes spots to develop on the skin, usually on the face, back and chest..  The spots can range from blackheads and whiteheads which are often mild, to inflamed pus-filled pustules and cysts, which can be severe ...

Mirvaso (brimonidine)
MIRVASO® (BRIMONIDINE) TOPICAL GEL, 0.33%* IS THE FIRST & ONLY FDA-APPROVED TREATMENT DEVELOPED AND INDICATED FOR PERSISTENT FACIAL REDNESS OF ROSACEA Mirvaso® (brimonidine) topical gel, 0.33% is an alpha adrenergic agonist indicated for th...


Corporate Database Quicklinks



Searches Linking to this Company Record